Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
BioChemistry Department, Cairo General Hospital, Egypt.
Eur J Med Chem. 2016 Nov 10;123:803-813. doi: 10.1016/j.ejmech.2016.08.013. Epub 2016 Aug 10.
Two new series of N-substituted indole derivatives 4a-l and 5a-h were synthesized. Their chemical structures were confirmed using spectroscopic tools including IR, (1)H NMR, (13)C NMR mass spectroscopy and elemental analyses. The results showed no significant cytotoxic activity on either cancer or normal human cells. Anti-inflammatory activity for all target compounds was evaluated in vitro. Compounds 5a-h were found to have better anti-inflammatory activity than 4a-l. The inhibitory activity of COX-2 and 5-LOX were tested for 5a-h. Three compounds, 5c, 5d and 5f showed excellent COX-2 inhibitory activity with IC50 ranging from 0.98 to 1.23 μM compared to the reference celecoxib (1.54 μM). These compounds had a reasonable selectivity index between 7.03 and 8.05. Additionally, p-methylbenzoyl derivative 5g (IC50 = 5.78 μM) had superior 5-LOX inhibitory activity, higher than quercetin. 5e was close to quercetin in its LOX inhibitory activity. Compounds 5a-h were docked inside the active site of COX-2 and 5-LOX enzymes.
合成了两个新的 N-取代吲哚衍生物系列 4a-l 和 5a-h。使用包括红外光谱(IR)、(1)H NMR、(13)C NMR 质谱和元素分析在内的光谱工具确认了它们的化学结构。结果表明,这些化合物对癌细胞和正常人类细胞均没有显著的细胞毒性。在体外评估了所有目标化合物的抗炎活性。发现 5a-h 比 4a-l 具有更好的抗炎活性。测试了 5a-h 对 COX-2 和 5-LOX 的抑制活性。三种化合物,即 5c、5d 和 5f,对 COX-2 的抑制活性优异,IC50 范围为 0.98-1.23 μM,与参考药物塞来昔布(1.54 μM)相比。这些化合物的选择性指数在 7.03 到 8.05 之间。此外,p-甲基苯甲酰基衍生物 5g(IC50=5.78 μM)对 5-LOX 的抑制活性较高,优于槲皮素。5e 在 LOX 抑制活性方面与槲皮素接近。将化合物 5a-h 对接入 COX-2 和 5-LOX 酶的活性部位。